Emerging digital technologies are fueling innovation and transforming the life sciences industry by introducing new business models, products and services and enhancing patient experience. These technologies include robotic process automation (RPA), artificial intelligence (AI), machine learning (ML), blockchain, the Internet of Things (IoT), 3-D printing and augmented reality/virtual reality (AR/VR).
As always, these technologies are unlocking great opportunities as well as enormous risks. Life sciences companies will need to speed decision-making before adopting new technology to keep pace with more nimble, fast-paced, digital-savvy players who are beginning to pose a threat by introducing technology-enabled new business models.
This white paper explores the five themes, together with key technological advances and evolving business models that are transforming the life sciences industry.
To get ahead in the industrial space amid the prolonged pandemic, manufacturers must embrace holistic agility and resilience, and democratize access to applications and data. This whitepaper provides a roadmap ahead.
Covid-19 served as a wake-up call to manufacturers – one that has accelerated the need for digitalization. To find out what technology investments will propel manufacturers forward, we conducted ESI ThoughtLab. Learn more in our e-Book.
Learn how 19 businesses have increased efficiency, realized cost savings and prepared for growth by applying digital technologies to their supply chains.
WHO believes that 80% of all visual impairment caused by Diabetic Retinopathy can be cured with regular screening and early detection. Follow our journey in developing an AI-based diagnostic tool to speed up DR identification.
